Question 1

What insurance policy changes affect CPT 33947?

Accepted Answer

There are 3 tracked policy changes affecting CPT 33947, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Question 2

Which payers have updated policy for CPT 33947?

Accepted Answer

Payers that have issued tracked updates for CPT 33947 include: Aetna.

Question 3

How do I get notified when CPT 33947 policy changes?

Accepted Answer

Create a free account at PolicyChanges.app and save a search filtered to CPT 33947. You will receive a daily digest email whenever a new policy change references this code.

Question 4

Why do payers change policies for CPT 33947?

Accepted Answer

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

33947 Insurance Policy Changes

Nirsevimab-alip (Beyfortus) (CPB 1038, reviewed 2025-10-09)

Extracorporeal Membrane Oxygenation (ECMO) (CPB 0546, reviewed 2025-08-21)

Extracorporeal Membrane Oxygenation (ECMO) (CPB 0546, reviewed 2026-08-27)